PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 887843

[Postheparin lipolytic effect in diffuse hepatic diseases].

R Romero·S Masdeu·J C Frison·M R Ras·J Rubies-Prat·R Bacardi
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Fatty Acids, NonesterifiedHeparinHepatitisHumansLipid MobilizationLipoproteinsLiver CirrhosisTriglyceridesEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Romero, S Masdeu, J C Frison, M R Ras, J Rubies-Prat, R Bacardi. 1977-05-15. [Postheparin lipolytic effect in diffuse hepatic diseases].. https://pubmed.ncbi.nlm.nih.gov/887843/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Involvement of novel PKC isoforms in FFA induced defects in insulin signaling.

Involvement of novel PKCs (nPKCs) in the negative regulation of insulin-signaling pathway is a current interest of many workers investigating the cause for insulin resistance and type 2 diabetes. Free fatty acids (FFAs) are recently shown to be the major players in inducing insulin resistance in insulin target cells. They are also found to be involved in activating nPKCs associated with the impairment of insulin sensitivity. In this overview, we describe PKC delta, theta and epsilon linked to the FFA induced damage of insulin-signaling molecules.

Fatty Acids, Nonesterified↗